Logo

American Heart Association

  36
  0


Final ID:

Lipids, Vascular Inflammation and Gene-editing Therapies on Cardiovascular Disease and Metabolic Disorders

  • Rayner, Katey  ( UNIV OTTAWA HEART INST , Ottawa , Ontario , Canada )
  • Musunuru, Kiran  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Zhang, Hanrui  ( COLUMBIA UNIVERSITY MEDICAL CENTER , New York , New York , United States )
  • Author Disclosures:
    Katey Rayner: DO NOT have relevant financial relationships | Kiran Musunuru: DO have relevant financial relationships ; Individual Stocks/Stock Options:Verve Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Beam Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Nava Therapeutics:Active (exists now) ; Advisor:Capstan Therapeutics:Active (exists now) ; Advisor:LEXEO Therapeutics:Active (exists now) ; Ownership Interest:Variant Bio:Active (exists now) ; Advisor:Verve Therapeutics:Active (exists now) | Hanrui Zhang: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Vascular Calcification and Gene-editing Therapy in Peripheral and Cardiovascular Disease

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Clinical Implications, Mechanisms and Public Health Strategies in Cardiovacular Disease

Martin Kathleen, Musunuru Kiran, Creager Mark, Pradhan Aruna

The Impact of Calcification on PAD Severity in High-Risk Populations

Morrison Alan, Brewster Luke, Miano Joseph, Turner Mandy

You have to be authorized to contact abstract author. Please, Login
Not Available